Optimization of biaryl Selective HDAC1&2 Inhibitors (SHI-1:2)
- 15 January 2008
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 18 (2) , 726-731
- https://doi.org/10.1016/j.bmcl.2007.11.047
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Benzo[b]thiophene-based histone deacetylase inhibitorsBioorganic & Medicinal Chemistry Letters, 2007
- Role for Histone Deacetylase 1 in Human Tumor Cell ProliferationMolecular and Cellular Biology, 2007
- HDAC inhibitors: Clinical update and mechanism-based potentialPublished by Elsevier ,2007
- VorinostatNature Reviews Drug Discovery, 2007
- Targeting histone deacetylases for the treatment of cancer and inflammatory diseasesJournal of Cellular Physiology, 2006
- A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibitionNature Genetics, 2006
- Histone deacetylase inhibitors: Multifunctional anticancer agentsCancer Treatment Reviews, 2006
- Prospects: Histone deacetylase inhibitorsJournal of Cellular Biochemistry, 2005
- On the Function of the 14 Å Long Internal Cavity of Histone Deacetylase-Like Protein: Implications for the Design of Histone Deacetylase InhibitorsJournal of Medicinal Chemistry, 2004
- Histone Deacetylase InhibitorsJournal of Medicinal Chemistry, 2003